125
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Nail psoriasis as a severity indicator: results from the PsoReal study

, , , , &
Pages 1-6 | Published online: 22 Dec 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matilde Iorizzo & Antonella Tosti. (2023) Updates in treatment and impact of nail psoriasis. Expert Review of Clinical Immunology 19:9, pages 1091-1100.
Read now
Aikaterini Kyriakou, Aikaterini Patsatsi & Dimitrios Sotiriadis. (2013) Biologic agents in nail psoriasis: efficacy data and considerations. Expert Opinion on Biological Therapy 13:12, pages 1707-1714.
Read now

Articles from other publishers (8)

Júlia Szebényi, Péter Oláh & Rolland Gyulai. (2022) Comparison of the Objective Severity and the Esthetic Perception of Nail Symptoms in Psoriasis. Skin Appendage Disorders 8:4, pages 295-301.
Crossref
Christine Blome, Matthias Augustin & Toni Maria Klein. (2021) Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments. American Journal of Clinical Dermatology 22:6, pages 747-755.
Crossref
Antonio Costanzo, Filomena Russo, Marco Galluzzo, Luca Stingeni, Roberta Scuderi, Leonardo Zichichi, Manuela Papini, Luisa Di Costanzo, Andrea Conti, Martina Burlando, Andrea Chiricozzi, Francesca Maria Gaiani, Cristina Mugheddu, Maria Letizia Musumeci, Paolo Gisondi, Stefano Piaserico, Paolo Dapavo, Marina Venturini, Gianluca Pagnanelli, Paolo Amerio, Concetta Potenza, Ketty Peris, Franca Cantoresi, Sara Trevisini, Francesco Loconsole, Annamaria Offidani, Santo Raffaele Mercuri, Viviana Lora, Francesca Prignano, Marta Bartezaghi, Giovanni Oliva, Elisabetta Aloisi & Roberto Orsenigo. (2021) Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study. Acta Dermato-Venereologica 101:10, pages adv00576.
Crossref
Claire R. Stewart, Leah Algu, Rakhshan Kamran, Cameron F. Leveille, Khizar Abid, Charlene Rae & Shari R. Lipner. (2021) The Impact of Nail Psoriasis and Treatment on Quality of Life: A Systematic Review. Skin Appendage Disorders 7:2, pages 83-89.
Crossref
N. S. Rudneva, T. G. Sadunashvili, Ya. Yu. Chumakova & E. V. Natarova. (2019) Certolizumab pegol for treatment of severe plaque psoriasis: local experience. Medical alphabet 2:26, pages 34-40.
Crossref
M. Augustin, C. Blome, A. Costanzo, E. Dauden, C. Ferrandiz, G. Girolomoni, R. Gniadecki, L. Iversen, A. Menter, K. Michaelis-Wittern, A. Morita, H. Nakagawa & K. Reich. (2014) Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. British Journal of Dermatology 170:3, pages 591-598.
Crossref
Aikaterini Kyriakou, Aikaterini Patsatsi, Timoleon-Achilleas Vyzantiadis & Dimitrios Sotiriadis. (2014) Serum Levels of TNF- α , IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study . The Scientific World Journal 2014, pages 1-5.
Crossref
Romi Bloom & Antonella Tosti. 2014. Nail Psoriasis. Nail Psoriasis 43 55 .